Bigul

Shree Ganesh Remedies Ltd - 540737 - Board Meeting Intimation for Notice Of Board Meeting Pursuant To Regulation 29 Of SEBI (Listing Obligation And Disclosure Requirements) 2015.

Shree Ganesh Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/05/2019 ,inter alia, to consider and approve In compliance of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform you that a meeting of the Board of Directors of the Company will be held on Saturday, the 18th May 2019 at the registered office of the Company situated at Ankleshwar to consider, amongst other business, the followings; i. Approval of Audited Financial Results of the Company for the Quarter and Financial Year ended on 31st March, 2019. ii. Recommendation of Final Dividend on the Equity Shares, if any. Further in accordance with our intimation dated April 03, 2019 regarding Code of Conduct to Regulate, Monitor and Report Trading by Insiders of the Company pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015, the "Trading Window" for trading / dealing in the securities of the Company shall remain closed from 03rd April, 2019 to 20th May, 2019 (both days inclusive).
09-05-2019
Bigul

Shree Ganesh Remedies Ltd - 540737 - Format of Initial Disclosure to be made by an entity identified as a Large Corporate

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayShree Ganesh Remedies Ltd 2CININE414Y01015 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 1 4Highest Credit Rating during the previous FY NIL 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: ADITYA VIKRAMBHAI PATEL Designation: COMPANY SECRETARY EmailId: investors@ganeshremedies.com Name of the Chief Financial Officer: BHAVITABEN BHAVIK KUMAR JAIN Designation: CHIEF FINANCIAL OFFICER EmailId: cfo@ganeshremedies.com Date: 30/04/2019 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
30-04-2019
Bigul

Shree Ganesh Remedies Ltd - 540737 - Shareholding for the Period Ended March 31, 2019

Shree Ganesh Remedies Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2019. For more details, kindly Click here
20-04-2019
Bigul

Shree Ganesh Remedies Ltd - 540737 - Compliance Certificate Under Regulation 7(3) Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations,2015 For The Half-Year Ended On March 31, 2019.

With reference to the Above Subject matter we are sending herewith the certificate in terms of Regulation 7(3) of SEBI (Listing Obligations Disclosure Requirements) Regulations, 2015 duly signed by Bigshare Services Private Limited, Registrar and Share Transfer Agent and Compliance Officer of Shree Ganesh Remedies Limited for the half year ended on March 31, 2019. Please find in order in compliance to SEBI circular.
16-04-2019
Bigul

Shree Ganesh Remedies Ltd - 540737 - Certificate Under Regulation 40 (9) Of SEBI (Listing Obligations Disclosure Requirements) Regulations, 2015 For Half Year Ended On March 31, 2019.

With reference to the Above Subject matter we are sending herewith the certificate in terms of Regulation 40 (9) of SEBI (Listing Obligations Disclosure Requirements) Regulations, 2015 signed by Mr. Vishal Thawani of M/s. Vishal Thawani & Associates, Practicing Company Secretaries, for the half year ended on March 31, 2019. Please find in order in compliance to SEBI circular.
16-04-2019
Bigul

Shree Ganesh Remedies Ltd - 540737 - Statement Of Investor Complaints For The Quarter Ended March 2019

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- ADITYA VIKRAMBHAI PATELDesignation :- Company Secretary and Compliance Officer
16-04-2019
Bigul

Shree Ganesh Remedies Ltd - 540737 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015

We wish to inform you that we have updated the 'Code of Practice and Procedures for Fair Disclosure of Unpublished Price Sensitive Information' as required under SEBI (Prohibition of Insider Trading) Regulations, 2015. The revised code of conduct is uploaded on the website of the Company www.ganeshremedies.com
04-04-2019
Bigul

Shree Ganesh Remedies Ltd - 540737 - Closure of Trading Window

This is with reference to the circulars issued by BSE Limited, dated 2nd April, 2019 pertaining to clarification regarding trading restriction period. In complying with the aforesaid circular and pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, we wish to inform you that the Trading Window for dealing in securities of the Company shall remain closed with immediate effect till 48 hours after the announcement of the financial results of the Company for the quarter and financial year ended 31st March, 2019.
04-04-2019
Bigul

Shree Ganesh Remedies Ltd - 540737 - Statement Of Investor Complaints For The Quarter Ended December 2018

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- ADITYA PATELDesignation :- Company Secretary and Compliance Officer
12-01-2019
Next Page
Close

Let's Open Free Demat Account